Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Industry Outlook 2025-2029: Market Set to Cross $60.53 Billion Milestone

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Size By 2025?
The market size of devices for chronic obstructive pulmonary disease (COPD) and asthma has seen a substantial expansion in the past few years. The projections suggest an increase from $44.95 billion in 2024 to $47.83 billion in 2025, marking a compound annual growth rate (CAGR) of 6.4%. Factors like the increase in the elderly population, higher allergy rates, more government initiatives, an increase in clinical research and trials, and urbanization are contributing to this historical growth period.

How Big Is the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Size Expected to Grow by 2029?
In the upcoming years, the market for chronic obstructive pulmonary disease (COPD) and asthma devices is projected to experience robust growth, escalating to $60.53 billion by 2029 at a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this growth include an increased incidence of respiratory diseases, a surge in cigarette smoking, escalating levels of environmental pollution and breathing issues, a rise in the prevalence of respiratory diseases, increasing healthcare expenditures, and a growing demand for portable drug delivery devices. Key trends for the forecast period encompass technological advances, the incorporation of intelligent technology, tailored medicine, the use of biologics, and wearable respiratory monitoring devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-and-asthma-devices-global-market-report

Which Key Market Drivers Powering Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Expansion and Growth?
The rising incidence of respiratory ailments is projected to spur the expansion of the market for chronic obstructive pulmonary disease (COPD) and asthma devices. Respiratory illnesses involve a variety of conditions that affect the lungs and respiratory systems, including asthma, chronic obstructive pulmonary disease, pneumonia, and lung cancer, each affecting breathing and overall respiratory function. The uptick in respiratory diseases can be attributed to factors such as increasing levels of air pollution, shifts in climate patterns that affect allergens and pathogens, and lifestyle choices like smoking that jeopardize respiratory health. Devices for COPD and asthma serve an essential function in the holistic management and therapy of respiratory diseases, aiding patients in improving their respiratory health and overall quality of life. For example, the World Health Organization (WHO), a Switzerland-based special agency of the United Nations focused on global public health, reported in March 2023 that chronic obstructive pulmonary disease (COPD) was ranked as the third leading cause of death worldwide, with roughly 3.23 million cases of fatality. Moreover, about 90% of these fatalities occurred in individuals under 70 years of age in low- and middle-income countries (LMICs). Hence, the rising incidence of respiratory diseases fuels the expansion of the market for chronic obstructive pulmonary disease (COPD) and asthma devices.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Leading firms in the Chronic Obstructive Pulmonary Disease (COPD) and asthma devices market are prioritizing the creation of groundbreaking technologies. These include inhalation devices that incorporate digital health features for remote tracking and tailored treatment management. Inhalation devices, which deliver medication directly to the lungs, are a type of medical equipment. In May 2022, for example, Alkem Laboratories, a pharmaceutical firm based in India, launched the Innohaler. This dry powder inhaler (DPI) device is aimed at improving the lives of individuals living with asthma and COPD. The Innohaler is equipped with cutting-edge breath-activated technology that guarantees accurate medication administration with each breath, ensuring precise dosage and minimizing waste. Its intuitive design and interface offer simplicity of use for patients of any age. Its lightweight and compact structure heighten convenience for usage while traveling or outside of home, which also aids in upholding patients' commitment to their prescribed treatments.

What Are the Emerging Segments in the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
The chronic obstructive pulmonary disease (COPD) and asthma devices market covered in this report is segmented -

1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric

Subsegments:
1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories, Spacer Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18298&type=smp

Who Are the Global Leaders in the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, 3M Health Care, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Baxter International Inc., Omron Corporation, Smiths Medical Inc., Recipharm AB, Cipla Ltd., Teleflex Incorporated, Chiesi Farmaceutici SpA, Lincre Holdings Inc., Sunovion Pharmaceuticals Inc., Verona Pharma plc, Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd.

Which are the Top Profitable Regional Markets for the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Industry?
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2023. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18298

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.